Literature DB >> 21689985

Narcolepsy and psychiatry: an evolving association of increasing interest.

H A Droogleever Fortuyn1, P C Mulders, W O Renier, J K Buitelaar, S Overeem.   

Abstract

Gélineau originally described narcolepsy as a disease with an organic cause. However, the disorder had undeniable emotional triggers and psychiatric-like expressions, and soon a psychiatric etiology of narcolepsy became a seriously considered option. In fact, the psychiatric view dominated scientific thinking for a long time, not necessarily to the benefit of patients. When hypocretin (orexin) defects were proven to be the cause of narcolepsy Gélineau's original disease model was shown to be right. However, the psychiatric symptoms of the disease were not forgotten afterwards, but gained a different significance: as psychiatric expressions of a brain disease. These symptoms, such as anxiety and eating disorders, can be highly debilitating and warrant clinical attention. Here, we describe the role of psychiatry in the history of narcolepsy, showing their evolving association.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21689985     DOI: 10.1016/j.sleep.2011.01.013

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  18 in total

1.  Effect of psychostimulants on impulsivity and risk taking in narcolepsy with cataplexy.

Authors:  Sophie Bayard; Muriel Croisier Langenier; Yves Dauvilliers
Journal:  Sleep       Date:  2013-09-01       Impact factor: 5.849

Review 2.  Role of orexin in the pathophysiology of depression: potential for pharmacological intervention.

Authors:  Mathieu Nollet; Samuel Leman
Journal:  CNS Drugs       Date:  2013-06       Impact factor: 5.749

3.  Psychosocial Profile and Quality of Life in Children With Type 1 Narcolepsy: A Case-Control Study.

Authors:  Francesca Letizia Rocca; Elena Finotti; Fabio Pizza; Francesca Ingravallo; Michela Gatta; Oliviero Bruni; Giuseppe Plazzi
Journal:  Sleep       Date:  2016-07-01       Impact factor: 5.849

4.  Hypersomnia hiding a bipolar disorder.

Authors:  Iolanda Martino; Antonella Bruni; Maria Grazia Vaccaro; Michele Trimboli; Giuseppe Borzì; Pasquale De Fazio; Angelo Labate
Journal:  Neurol Sci       Date:  2017-07-07       Impact factor: 3.307

5.  Dual cases of type 1 narcolepsy with schizophrenia and other psychotic disorders.

Authors:  Francesca Canellas; Ling Lin; Maria Rosa Julià; Antonio Clemente; Cristofol Vives-Bauza; Hanna M Ollila; Seung Chul Hong; Susana M Arboleya; Mali A Einen; Juliette Faraco; Marcelo Fernandez-Vina; Emmanuel Mignot
Journal:  J Clin Sleep Med       Date:  2014-09-15       Impact factor: 4.062

Review 6.  Hypersomnolence, Hypersomnia, and Mood Disorders.

Authors:  Lucie Barateau; Régis Lopez; Jean Arthur Micoulaud Franchi; Yves Dauvilliers
Journal:  Curr Psychiatry Rep       Date:  2017-02       Impact factor: 5.285

7.  Increased mortality in narcolepsy.

Authors:  Maurice M Ohayon; Jed Black; Chinglin Lai; Mark Eller; Diane Guinta; Arun Bhattacharyya
Journal:  Sleep       Date:  2014-03-01       Impact factor: 5.849

8.  Narcolepsy with cataplexy mimicry: the strange case of two sisters.

Authors:  Fabio Pizza; Stefano Vandi; Francesca Poli; Keivan Kaveh Moghadam; Christian Franceschini; Claudia Bellucci; Carlo Cipolli; Francesca Ingravallo; Giuliana Natalini; Emmanuel Mignot; Giuseppe Plazzi
Journal:  J Clin Sleep Med       Date:  2013-06-15       Impact factor: 4.062

9.  Hypocretin/Orexin Peptides Alter Spike Encoding by Serotonergic Dorsal Raphe Neurons through Two Distinct Mechanisms That Increase the Late Afterhyperpolarization.

Authors:  Masaru Ishibashi; Iryna Gumenchuk; Kenichi Miyazaki; Takafumi Inoue; William N Ross; Christopher S Leonard
Journal:  J Neurosci       Date:  2016-09-28       Impact factor: 6.167

10.  Frequencies and Associations of Narcolepsy-Related Symptoms: A Cross-Sectional Study.

Authors:  Lenise Jihe Kim; Fernando Morgadinho Coelho; Camila Hirotsu; Paula Araujo; Lia Bittencourt; Sergio Tufik; Monica Levy Andersen
Journal:  J Clin Sleep Med       Date:  2015-12-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.